Executive Summary
VA awarded $381M in contracts signaling robust demand for health IT infrastructure (Oracle, Deloitte) and recurring medical supplies (Medline), with $900M+ in total potential via options. Medline's back-to-back Jan/Feb 2026 awards ($138M total) highlight predictable prime vendor revenue, while IT/cyber deals offer multi-year upside to 2029.
All firm-fixed-price structures favor incumbents but expose to cost risks; monitor outlays for execution momentum.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from March 14, 2026.
Investment Signals (2)
- VA locks in $138M Medline for 2026 medical supplies (HIGH)▲
Consecutive one-month awards for Jan/Feb prime vendor expenditures confirm steady VA demand for NAICS 423450 wholesaling.
- $900M+ IT/cyber potential via Oracle/Deloitte (HIGH)▲
Oracle's $784M EHRM and Deloitte's $185M cybersecurity deals provide unexercised options worth $725M combined, non-competed/competitive wins in VA health tech.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
$0 outlays in 3/4 contracts signal potential funding delays; firm-fixed-price exposes all to cost overruns.
- Competitive [MEDIUM RISK]▼
Heavy subaward reliance (Oracle $10M, Deloitte $25M) may erode margins; Medline's short monthly terms risk non-renewal.
Opportunities (2)
- ◆
Unexercised options add $725M potential (Oracle $608M, Deloitte $118M) in EHRM/cybersecurity.
- ◆
Repeat monthly prime vendor awards position Medline for annualized $800M+ VA revenue stream.
Sector Themes (2)
- ◆
Non-competitive EHRM (Oracle) and competitive cyber (Deloitte) awards total $243M obligated with $900M ceiling emphasize digital transformation.
- ◆
Medline's $138M Jan/Feb awards under open competition signal stable prime vendor spending amid VA supply chain focus.
Watch List (3)
- 👁
{"entity"=>"Medline Industries", "reason"=>"Dominates 36% of obligated value with repeat awards; tests VA prime vendor continuity.", "trigger"=>"March 2026 award >$65M or funding outlay start"}
- 👁
{"entity"=>"Oracle Health", "reason"=>"Largest award (46% of total) with $608M options in non-competed EHRM space.", "trigger"=>"First outlays or option exercise by Q2 2026"}
- 👁
{"entity"=>"Deloitte", "reason"=>"Only contract with outlays ($38M of $67M); $118M options to 2029.", "trigger"=>"Subaward margins or extension beyond 2026"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 4 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: VA Healthcare & Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals